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Short Title: Cocoa, blood flow and anabolic responses  
ABSTRACT 
The anabolic effects of nutrition on skeletal muscle may depend on adequate skeletal muscle 
perfusion, which is impaired in older people. Cocoa flavanols have been shown to improve 
flow-mediated dilation, an established measure of endothelial function. However, their effect 
on muscle microvascular blood flow is currently unknown. Therefore, the objective of this 
study was to explore links between the consumption of cocoa flavanols, muscle 
microvascular blood flow and muscle protein synthesis (MPS) in response to nutrition in 
older men. To achieve this objective leg blood flow (LBF), muscle microvascular blood 
volume (MBV) and MPS were measured under postabsorptive and postprandial (I.V glamin, 
dextrose to sustain glucose ~7.5 mmol·l-1) conditions in 20 older men. Ten of these men were 
studied with no cocoa flavanol intervention and a further 10 were studied with the addition of 
350 mg of cocoa flavanols at the same time as nutrition began. Leg [femoral artery] blood 
flow was measured by Doppler ultrasound, muscle MBV by contrast-enhanced ultrasound 
(CEUS) using DefinityTM perflutren contrast agent and MPS using [1, 2-13C2] leucine tracer 
techniques. Our results show that although older individuals do not show an increase in LBF 
or MBV in response to feeding, these absent responses are apparent when cocoa flavanols are 
given acutely with nutrition. However this restoration in vascular responsiveness is not 
associated with improved MPS responses to nutrition. We conclude that acute cocoa flavanol 
supplementation improves muscle macro- and microvascular responses to nutrition, 
independently of modifying muscle protein anabolism. 
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INTRODUCTION 
Skeletal muscles facilitate whole-body locomotory function but also represent the bodyÕs 
largest metabolically active protein reservoir and glucose disposal site (Wolfe 2006). Given 
these crucial functional and metabolic duties ascribed to muscles, age-related sarcopenia (i.e., 
atrophy) represents a major health problem. Indeed, in older-aged people habitually suffer 
reductions in strength and power, which are exacerbated by sarcopenia and culminate in 
dynapenia and loss of independence, resulting in a cyclical syndrome of frailty (Fried et al. 
2001). 
 
In addition to frailty, the link between ageing, sarcopenia and the development of 
cardiovascular and metabolic-related diseases is striking. For example, decreased arterial 
compliance in older age leads to hypertension and coronary artery disease (DeSouza et al. 
2002; Dinenno et al. 1999; Lind & Lithell 1993). In addition, when compared to younger 
individuals, older individuals exhibit 20-30% reductions in limb conduit artery blood flow 
under both postabsorptive (Donato et al. 2006) and postprandial conditions (Skilton et al. 
2005), due to both a decrease in capillary number (Coggan et al. 1992) and increased 
sensitivity to vasoconstrictors such as alpha-adrenergic innervation (Barrett-OÕKeefe et al. 
2013). Such blunted blood flow responses may contribute to age-related declines in anabolic 
responses to feeding (Durham et al. 2010), by reducing delivery and/or utility of insulin and 
amino acids (AA) in muscle (Clark et al. 2003; Timmerman et al. 2010).  Thus, it is likely 
that determining strategies for maintaining limb blood flow in older individuals will be 
important for both maintaining muscle mass and reducing cardiovascular/ metabolic disease 
risk.  
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In addition to total limb blood flow, another mediator of insulin and AA delivery to the 
muscle is the distribution of blood flow between so-called nutritive and non-nutritive routes 
(Clark et al. 2006; Clark 2008; Durham et al. 2010), as reduced nutritive blood flow may 
contribute to the anabolic resistance observed with ageing (Cuthbertson et al. 2005; Wilkes et 
al. 2009). We have previously shown that in young individuals pharmacological enhancement 
of ÔnutritiveÕ muscle microvascular blood flow was not associated with increases in muscle 
protein synthesis (Phillips et al. 2014). However, in older individuals it has been reported that 
there may be a positive relationship between enhanced muscle microvascular blood flow and 
muscle protein anabolic responses to nutrition (Timmerman et al. 2012).  
 
A substantial body of epidemiological and experimental evidence has established that dietary 
interventions increasing the intake of plant-derived nutritional sources are inversely 
associated with cardiovascular disease risk (Joshipura et al. 2001). These beneficial effects 
have been linked to flavanols, a sub-group of flavonoids Ð the polyphenolic family of anti-
oxidant chemicals, which are found in abundance in various foods (Heiss et al. 2005), 
including, but not limited to red wine, black tea, apples, onions and cocoa (Campia & Panza 
2008). The benefits of flavanol consumption are purported to be due to increased nitric oxide 
(NO) synthase activity and therefore an increased supply of bio-active NO (Fisher et al. 2003; 
Karim et al. 2000), with numerous studies showing that both acute (Duffy et al. 2001; Engler 
et al. 2004; Heiss et al. 2003; Leikert et al. 2002) and chronic flavanol supplementation can 
improve endothelium dependent vasodilation (Fisher et al. 2003; Karim et al. 2000). Interest 
in flavanols spread when initial beliefs that the acidic environment of the stomach degraded 
flavanol oligomers were disproven (Kwik-Uribe & Bektash 2008; Rios et al. 2002). Indeed 
once in the upper intestine, flavanols monomers and dimers can be absorbed and cocoa 
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flavanols monomers/ dimers have been shown to appear in plasma within 30 to 60 minutes 
post-consumption (Richelle et al. 1999; Schroeter et al. 2006). 
 
Interest in cocoa flavanols in particular was triggered by the finding that Kuna Indians living 
off the coast of Panama had a significantly lower incidence of vascular-related diseases 
compared to those living in Panama city (Bayard et al. 2007; Hollenberg et al. 1997), with 
dietary habits, and specifically the high intake of home-prepared cocoa found to be the most 
likely candidate for this disparity (Fisher & Hollenberg 2005). As with other forms of 
flavanols numerous studies have provided evidence that cocoa flavanols can enhance 
endothelial function in healthy individuals (Monahan et al. 2011), smokers (Heiss et al. 
2005), diabetics (Balzer et al. 2008), hypertensive patients (Grassi et al. 2005), patients with 
coronary artery disease (Heiss et al. 2010) and heart transplant recipients (Flammer et al. 
2007). However, whether cocoa flavanols can improve microvascular responses to nutrition 
is wholly unknown.  
 
Our objective was to determine the effect of acute cocoa flavanol supplementation on muscle 
microvascular blood flow and subsequent muscle protein synthetic responses to nutrition 
using an I.V feeding strategy. We hypothesised that acute cocoa flavanol supplementation 
would improve muscle microvascular blood flow responses to feeding and that this would be 
associated with improved muscle protein synthetic responses.    
 
MATERIALS AND METHODS 
Subject characteristics 
We recruited two groups of older men who were matched for age, body mass index (BMI) 
and baseline physiology (Table 1). The first group (Control (CON): n=10, 72.3±1.4 y; BMI 
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26.5±1.2 kg·m2) were studied with no cocoa flavanol supplementation. The second group 
were studied with an acute dose of 350 mg cocoa flavanol supplementation (CocoaVia¨, 
Mars Botanical, Mars Inc., MD, USA) during their study day (Cocoa (CC): n=10, 70.6±1.4 y; 
BMI 25.0±0.8 kg·m2). The 350 mg dose was chosen as this dose is similar to the acute dose 
at which improvements in indices of cardiovascular function have been observed (Francis et 
al. 2006; Mogollon et al. 2013; Sansone et al. 2015) and closely represents the dose given 
during chronic intervention studies (Balzer et al. 2008; Engler et al. 2004; Heiss et al. 2015; 
Muniyappa et al. 2008). !
All subjects were initially screened by means of a medical questionnaire, physical 
examination and resting ECG, with exclusions for overt muscle wasting (>2 SD below age 
norms) (Baumgartner et al. 1998), metabolic, respiratory or cardiovascular disorders or other 
signs and symptoms of ill-health. All subjects had normal blood chemistry, were 
normotensive (BP<140/90) and were not prescribed medication. All subjects performed 
activities of daily living and recreation but did not routinely participate in formal exercise 
regimes. All subjects gave their written, informed consent to participate after all procedures 
and risks were explained. This study was approved by The University of Nottingham Ethics 
Committee, complied with the Declaration of Helsinki and was registered at clinicaltrials.gov 
(NCT01734616).  
 
Acute studies 
Subjects were instructed to refrain from strenuous activity for 72 h prior to each study day 
and from alcohol and caffeine for 24 h. Subjects fasted from 2100h the night before (water ad 
libitum) and arrived to the laboratory via non-active means at 0900h. Subjects then had 
polyethylene catheters inserted into the antecubital veins of both arms (one for tracer infusion 
and the other for perflutren microbubble infusion) and the femoral vein of one leg (for venous 
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blood sampling). Blood samples were taken every 20 min. A primed, continuous infusion 
(0.7 mg·kg-1, 1 mg·kg·h-1) of [1, 2-13C2] leucine tracer (99 atoms %; Cambridge Isotopes Ltd, 
Cambridge, MA) was started at 0 min and maintained for the duration of the study with an 
increase to 1.2 mg·kg·h-1 at 130 min when a continuous I.V infusion of Glamin was started 
(102mg·kg·h-1, providing ~20 g AA) and 20% dextrose infused at a rate to maintain blood 
glucose between 7-7.5 mmol·l-1 (for Glamin composition see Table 2). The CC group was 
also provided with a single dose of 350 mg cocoa flavanol supplementation as I.V nutrition 
began. Muscle biopsies of m. vastus lateralis were taken at 0, 120 and 250 min using the 
conchotome biopsy technique (Dietrichson et al. 1987), with 1% lignocaine as local 
anaesthetic. The muscle tissue was washed in ice-cold saline to remove excess blood with 
visible fat and connective tissue removed, before being snap frozen in liquid nitrogen and 
stored at -80¡C until further analysis (Figure 1).  
 
Leg Blood Flow (LBF)  
After 50 min lying supine, measurements of LBF (femoral artery) were made over 40 min, 
with these values were designated as BASAL. This was repeated at 180 min (50 min after the 
start of Glamin and dextrose infusions) with these measurements labelled as FED. A mean 
value from three measurements on each leg was used to obtain the final value, no significant 
differences were observed between the three measurements. LBF was measured using 
Doppler ultrasound (iU22; Philips Ultrasound, CA, USA). All measurements were taken with 
the subject supine, with no visual or aural stimuli. A linear array 9-3 MHz frequency probe 
(Philips Ultrasound) was used to measure mean blood velocity and arterial lumen diameter in 
the common femoral artery of one leg. Measurements were made 2-3 cm proximal to the 
bifurcation of the femoral artery to minimize the effect of turbulence; the insonation angle 
was <60¡. Arterial lumen diameter (mm) was measured by video callipers for each 
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measurement and defined as the maximum distance between the media-adventitia interface of 
the near wall and the lumen-intima interface of the far wall of the vessel. LBF (l.min-1) was 
calculated as: mean blood velocity (cm.sec-1) × π × (femoral artery radius (mm))2)/1000 × 60. 
 
Microvascular Blood Volume (MBV) 
At 110 min (BASAL) and 240 min (110 min after the start of nutrition (FED)), measurements 
of MBV in the m. vastus lateralis were made using contrast enhanced ultrasound (CEUS), as 
previously described (Sj¿berg et al. 2011). In brief, a linear array transducer (L9-3 MHz; 
Philips Ultrasound) was fixed to the thigh for the duration of the study to allow cross-
sectional imaging of the m. vastus lateralis. A 1.5ml suspension of perflutren (Definity; 
Lantheus Medical Imaging, MA, USA) microbubbles was diluted to 20ml and infused at a 
rate of 1.2ml·min-1. Real-time imaging was performed at a low-mechanical index (0.08) for 9 
min to allow attainment of a steady-state microbubble signal. After this period a high 
mechanical index (1.20) flash was used to destroy the microbubbles, allowing recording of 
the replenishment of the microbubbles in the vasculature within the ultrasound beam during a 
45 sec replenishment period. The acoustic index (AI) generated from the resonating 
microbubbles is proportional to the microbubble concentration in the region of interest (ROI) 
(Wei et al. 1998). Four destruction-replenishment cycles were recorded for each MBV 
measurement (BASAL and FED). 
 
Data from these recordings were exported to quantification software (Q-Lab; Philips 
Ultrasound) for analysis. ROI were drawn free-hand and selected to be free of connective 
tissue and large vessels. The selected ROI was copied for each recording to ensure that the 
ROI was identical for both BASAL and FED conditions. The AI obtained during the first 0.5 
sec was averaged and subtracted from the AI recorded during the remaining time to eliminate 
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background noise and contribution from any rapid filling vessels in the ROI. Calculations 
were made in accordance to Wei et al., with AI vs. time curves fitted to the equation: y = A[1 
Ð e-β(t-βt)], where t is time (s), Bt the time used for background subtraction, y is the acoustic 
intensity at any given t, A is the plateau AI defined as MBV and β is the flow rate constant 
(1/s) that determines the rate of rise of AI, proportional to microvascular flow velocity (MFV;  
(Krix et al. 2005; Wei et al. 1998)). The product of Aβ with the unit volume blood-1·volume 
tissue-1·second-1 is proportional to microvascular blood flow (MBF) (Mitchell et al. 2013).  
 
Muscle Protein Synthesis (MPS) 
Approximately 20mg of muscle tissue was used for measures of MPS, as previously 
described (Kumar et al. 2012). In brief, the myofibrillar pellet was precipitated by 
homogenisation and centrifugation with the soluble myofibrillar protein then precipitated by 
perchloric acid. Protein-bound AAÕs were released by acid hydrolysis in Dowex H+ resin 
slurry before being purified by ion exchange chromatography on Dowex H+ resin. The AAÕs 
were then derivatized as their n-acetyl-N-propyl esters as previously described (Wilkinson et 
al. 2008). Incorporation of [1, 2-13C2] leucine into protein was determined by gas 
chromatography-combustion-isotope ratio mass spectrometry (Delta Plus XP, Thermofisher 
Scientific, Hemel Hempstead, UK) using our standard techniques (Babraj et al. 2005), with 
the fractional synthetic rate (FSR) of myofibrillar protein determined from the incorporation 
of [1, 2-13C2], using the precursor labelling of venous α-KIC between subsequent muscle 
biopsies (Kumar et al. 2009). Plasma phenylalanine concentrations were measured via our 
standard techniques using a 2H2 phenylalanine internal standard, with reference to a standard 
curve of known concentration (Phillips et al. 2015).  
 
Immunoblotting and Plasma Insulin 
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To investigate the possible effects of cocoa flavanols via enhanced LBF/ MBV on anabolic 
signalling we measured protein phosphorylation of AKT and P70S6K1 (as likely indicators 
of such activity) in response to feeding. We also measured protein phosphorylation of 
endothelial nitric oxide synthase (eNOS) to explore possible mechanisms for the increased 
responses in LBF/ MBV we observed with cocoa flavanol supplementation. The supernatant 
(sarcoplasmic fraction) obtained from the myofibrillar preparation described above, was 
standardized to a protein concentration of 1 mg·ml-1 by dilution with Laemmli buffer, mixed 
and heated at 95¡C for 5 min before 15 µg of protein/lane was loaded on to Criterion XT Bis-
Tris 12% SDS-PAGE gels (Bio-Rad, Hemel Hempstead, UK) for electrophoresis at 200 V for 
60 min. Proteins were electroblotted on to 0.2 µm PVDF membranes (Bio-Rad) at 100 V for 
30 min and membranes blocked in 5% low-fat milk in TBS-T (Tris Buffered Saline and 0.1% 
Tween-20; both Sigma-Aldrich, Poole, UK) for 1 h; membranes were rotated overnight with 
primary antibody (Cell Signalling Technology, Boston, USA) at 1:2000 at 4¡C. Membranes 
were washed (3×5 min) with TBS-T and incubated for 60 min at room temperature with 
HRP-conjugated anti-rabbit secondary antibody (Cell Signalling Technology, Hertfordshire, 
UK), before further washing (3×5 min) with TBS-T and incubation for 5 min with ECL 
reagents (Enhanced chemiluminescence kit; Immunstar; Bio-Rad, Hemel Hempstead, UK). 
Blots were imaged and quantified by peak density within the linear range using the Chemidoc 
XRS system (Bio-Rad, Hemel Hempstead, UK). Coomassie staining was used to correct for 
loading (Welinder & Ekblad 2011). 
 
Postabsorptive and fed plasma insulin concentrations were measured using undiluted samples 
and high-sensitivity insulin enzyme linked immunosorbent assays (ELISA; DRG Instruments 
GmbH, Marburg, Germany) according to manufacturerÕs protocol. 
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Statistical analyses 
Statistical analyses were performed using Graph Pad Prism Version 6.00 (La Jolla, CA, 
USA). All data are reported as means ± SEM with the threshold for significance set at P<0.05 
with trends reported as P<0.1. We applied Students t-tests to assess LBF, MBV, MPS, plasma 
insulin and α-KIC responses to nutrition and ANOVA with Bonferroni post-hoc analysis to 
compare between the groups. 
 
RESULTS 
Measures of LBF 
The CON group did not demonstrate increased LBF in response to nutrition (0.32±0.04 vs. 
0.32±0.04 l·min-1), a response that was apparent in the CC group (0.47±0.03 vs. 0.54±0.04 
l·min-1, P<0.01). Although this is likely partly attributable to the higher BASAL LBF in the 
CC group (0.47±0.03 vs. 0.32±0.04 l·min-1, P<0.05), this disparate response to nutrition, 
resulted in FED LBF values that were significantly higher in the CC group compared to the 
CON group (0.54±0.04 vs. 0.32±0.04 l·min-1, P<0.05) (Figure 2). 
 
Measures of MBV 
In agreement with our previous work and the work of Sjoberg et al., we found that with an 
infusion of 1.2ml·min-1 of Definity microbubbles a plateau signal was achieved at 
approximately 6 min (Phillips et al. 2014; Sj¿berg et al. 2011). Based on this an infusion time 
of 9 min was used before the measurements of MBV were obtained. The combined I.V 
nutrition strategy of 20% Dextrose at a rate to achieve blood glucose of 7-7.5mmol·l-1 and 
102mg·kg·h-1 of Glamin (following a 34mg·kg-1 prime) was not able to elicit a significant 
increase in MBV in the CON group (AI: 1.52±0.18 vs. 1.62±0.19; 6%). The CC group did 
demonstrate a significant (20%) increase in MBV in response to nutrition (1.24±0.17 vs. 
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1.43±0.15, P<0.01; Figure 3). Neither group demonstrated a significant increase in flow rate 
constant (β-value) in response to nutrition (CON: BASAL, 0.13±0.02 vs. FED, 0.13±0.02; 
CC: BASAL, 0.11±0.01 vs. FED, 0.12±0.01). In keeping with the results for MBV, MBF 
(MBV×β-value) increased only in the CC group in response to nutrition (CON: BASAL, 
0.21±0.05 vs. FED, 0.21±0.04; CC: BASAL, 0.15±0.03 vs. FED, 0.17±0.03, P<0.05). 
 
Plasma Amino Acid and Keto-acid Concentrations 
Postabsorptive plasma phenylalanine concentrations were similar between the groups (CON: 
67.49 ± 3.34 vs. CC: 66.41 ± 2.08 µM) and increased significantly, but to the same extent in 
response to feeding in both groups (CON: 115.94 ± 4.34 vs. CC: 120 ± 4.13 µM; P<0.001). 
Steady-state KIC enrichment was also observed throughout both conditions (BASAL, CON: 
4.81 ± 0.21 vs. CC: 5.33 ± 0.21; FED, CON: 5.79 ± 0.21 vs. CC: 6.38 ± 0.18 APE) and was 
not significantly different between the groups.  
 
Myofibrillar MPS 
Contrary to the results for LBF and MBV, both groups demonstrated significant increases in 
MPS in response to feeding (CON: BASAL, 0.052±0.006 vs. FED, 0.074±0.006%·h-1; CC: 
BASAL, 0.042±0.005 vs. FED, 0.068±0.010%·h-1, both P<0.01). Neither the magnitude of 
this response (CON: 57±16 vs. CC: 73±20%), nor the BASAL (CON: 0.052±0.006 vs. CC: 
0.042±0.005%·h-1) or FED (CON: 0.074±0.006 vs. CC: 0.068±0.010%·h-1) MPS values were 
significantly different between the groups (Figure 4).  
 
Plasma Glucose and Insulin 
Despite the greater increase in LBF and MBV in response to feeding in the CC group this 
was not associated with an increased dextrose infusion to maintain blood glucose at 7-7.5 
mmol·l-1, as there was no significant difference between the groups (AUC, CON: 
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560.40±41.06 vs. CC: 479.80±42.75 ml·min-1; Figure 5). This was also true for FED plasma 
insulin values, which were not significantly different between the groups (AUC, CON: 
30.72±9.15 vs. CC: 53.02±9.51 µUnits·ml-1; Figure 5). 
 
Immunoblotting 
There were no differences in BASAL or FED phosphorylation values of P70S6K1 (CON: 
BASAL, 1.01±0.03; FED, 1.05±0.04; CC: BASAL, 0.91±0.05; FED, 0.81±0.09 Arbitrary 
unit of optical density (AU)), AKT (CON: BASAL, 1.18±0.06; FED, 1.16±0.16; CC: 
BASAL, 1.75±0.11; FED, 1.52±0.16 AU) or eNOS (CON: BASAL, 0.90±0.03; FED, 
1.00±0.16; CC: BASAL, 1.02±0.06; FED, 1.17±0.14 AU) between the groups. Neither group 
demonstrated a significant increase in phosphorylation of any of the aforementioned targets 
in response to nutrition. 
 
DISCUSSION 
In this study, we have for the first time explored the effect of acute cocoa flavanol 
supplementation upon muscle vascular and muscle protein anabolic responses to nutrition in 
older individuals. We report that LBF and MBF responses to feeding do not appear to be rate-
limiting for MPS in older men since acute cocoa flavanol supplementation alongside mixed 
macro-nutrient provision improved macro- and microvascular responses to nutrition but this 
did not enhance anabolic responses to nutrition. 
 
Previously we have shown that resistance exercise training (RE-T) can restore age-related 
reductions in LBF in response to feeding (Phillips et al. 2012), and more recently have 
discovered the same to be true for MBF (Phillips et al. 2015). This intervention however, 
required 20 weeks of whole-body RE-T, a commitment that even irrespective of time is not 
	 14	
achievable by all older individuals due to physical and/ or socio-economic constraints. In an 
attempt to find a more time-efficient method to improve vascular responses to nutrition, we 
employed a strategy whereby we infused methacholine - a pharmacological vasodilator, into 
the femoral artery of young, healthy males to assess the impact of pharmacological increases 
in LBF on both MBF and MPS. Interestingly in these individuals we found that 
methacholine, as expected, was able to increase macro- and microvascular responses to 
mixed macronutrient (I.V) ÒfeedingÓ, but that this was not associated with improved MPS 
responses (Phillips et al. 2014). We rationalised that this lack of association may be due to 
already optimal vascular and muscle protein synthetic responses to nutrition in the young that 
are not apparent in older individuals (Cuthbertson et al. 2005; Phillips et al. 2012). In 
addition, we considered the difficulties in applicability of a pharmacological agent as a 
health-based intervention tool and instead moved towards using cocoa flavanols, a 
neutraceutical agent that has already been shown to be well tolerated (Balzer et al. 2008) and 
effective at improving vascular function in a wide variety of healthy and disease-based 
cohorts (Heiss et al. 2010).     
 
In young and middle aged subjects, a well-defined response to nutrient intake is increased 
limb arterial blood flow (Raitakari et al. 2000) but as we reported previously, such responses 
are reduced or absent in older people (Phillips et al. 2012). Here we have again shown that 
age-related decrements in LBF are associated with impairments in muscle MBV responses to 
feeding, findings that are consistent with reports of decrements in fed-state forearm MBF 
(inferred from indirect measurements) (Skilton et al. 2005) and also the absence of increased 
muscle MBF in older people fed EAA and sucrose (Timmerman et al. 2012). Whereas it is 
well established that acute bouts of exercise enhance microvascular perfusion in both human 
(Vincent et al. 2006) and rodent muscle (Sj¿berg et al. 2011), the effects of an acute 
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neutraceutical intervention (in this case cocoa flavanols) on muscle MBF in response to 
nutrition, have until now remained poorly defined. Here, we have shown that 350 mg cocoa 
flavanols improved nutrient-dependent increases in both LBF and muscle MBF in older men.  
 
Contrary to the purported mechanisms for exercise-training induced improvements in MBF 
(which include angiogenesis (Gavin et al. 2007), capillarization (McCall et al. 1996) and 
vascular remodelling of the arteriolar network (Weber et al. 2013)), independent mechanisms 
must underlie the results observed in this acute intervention study as the compressed time-
frame negates the possibility for the mechanisms outlined above. Based on the well-
established improvements in endothelium dependent vasodilation afforded by the 
consumption of cocoa flavanols, possible mechanisms for this include altered: metabolite 
profiles (Schroeter et al. 2006), cell signaling pathways, gene expression and/ or protein 
activity (Middleton et al. 2000; Scalbert et al. 2005), although our results suggest that this 
improvement is not linked to insulin signaling pathways as there were no differences in 
plasma insulin, proximal insulin signaling (AKT) or dextrose requirement to maintain a fixed 
blood glucose between the groups.  
 
Although MPS increases after oral consumption (Atherton et al. 2010) or I.V infusions of 
essential AA are well accepted (Anthony et al. 2000; Bennet et al. 1990; Millward 2012) 
previous work by our group (Cuthbertson et al. 2005) and others (Volpi et al. 2000) has 
demonstrated Ôanabolic resistanceÕ, whereby older men demonstrate blunted (compared to 
those in younger men) fed-state increases in MPS. Such anabolic resistance has not only been 
conjectured by us and others to contribute to the sarcopenia of ageing but it also appears to be 
a common feature of many kinds of muscle atrophy (e.g. with immobilization (Glover et al. 
2008), reduced physical activity (Breen et al. 2013), heart failure (Toth et al. 2010), obesity 
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(Guillet et al. 2009; Murton et al. 2015) and cancer (Williams et al. 2012)), suggesting a final 
common pathway for a variety of insults resulting in diminished anabolism. Whereas the 
regulatory mechanisms of anabolic resistance remain poorly defined, possible links between 
reduced muscle MBF and diminished anabolic responses to plasma nutrient availability may 
be a general feature of a number of conditions.  
 
We have now defined the relationship between fed-state muscle protein anabolism and MBF 
in older individuals and against our expectations; we found that despite cocoa flavanols 
resulting in greater (in comparison with an independent age-matched group) fed-state LBF 
and MBF responses, increases in MPS were similar between groups. This finding was based 
on a 2-hour window of fed-state MPS investigation, the postprandial period that has been 
well defined by our group (Atherton et al. 2010; Mitchell et al. 2015a; Mitchell et al. 2015b). 
Indeed, our recent work has demonstrated that in older individuals, in response to both 20 g 
whey protein and 3 g leucine-enriched essential amino acids, anabolic responses are apparent 
over the 0-2 hour period but not evident over the subsequent 2-4 hours. Therefore it would 
seem that interventions aimed at increasing the acute amplitude of MPS are most critical and 
that the duration appears to be more fixed (in the absence of accompanying exercise 
(Drummond et al. 2008). Although using this study design we cannot be certain that longer 
measures of MPS would not have shown increases in MPS in the CC group, we predict this 
would not be the case. 
 
We also found that although cocoa flavanols improved vascular responses to nutrition, this 
was not associated with any enhancement of eNOS signaling. Indeed, the increases in MPS in 
both groups in response to feeding were not associated with enhancement of P70S6K1 or 
AKT signaling. These lack of associations are not however surprising given that the 
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relationship between the degree of fed-state AKT phosphorylation and that of its supposed 
metabolic effects are poorly related (Greenhaff et al. 2008). 
 
We acknowledge some potential study limitations. We were unable to obtain data on flavanol 
bioavailability for this study. However, flavanol plasma availability is known to occur within 
30-60 min of consumption (Richelle et al. 1999), demonstrating that flavanol bioavailability 
upon oral consumption occurs within our period of measurement and fits with our 
observation of an acute effect on blood flow. Due to the invasive nature of the acute studies 
we performed with multiple muscle biopsies and central (femoral venous) cannulation, we 
chose not to study the same cohort twice, choosing rather to minimize the sampling burden 
on our subjects. A fundamental limitation of the CEUS technique for measuring MBF is that 
it cannot be used to compare absolute values between individuals due to differences in the 
architecture of muscle blood vessels and therefore definition of ROI in different people; thus, 
we were unable to directly compare values between our subjects. However, delta changes 
within subjects in each group in response to a stimulus is a robust measure and thus the 20% 
feeding-induced increase in MBV in the CC group is comparable to the CON group that 
showed no significant change in MBV in response to our feeding regime. Furthermore, the 
effects (if any) of blood flow in modulating muscle protein turnover may depend, in a 
currently unknown way upon the mode of feeding and the composition or volume of the feed, 
so that our results may not be applicable to the effects of other patterns of feeding. For 
example, these results may not be fully representative of oral feeding, where additional 
factors such as gut hormones (e.g. incretins) may elicit an effect. However, although most of 
the non-essential AAÕs would be sequestered on first pass splanchnic extraction, the essential 
AAÕs (which impact MPS) would be largely peripherally available to muscle minimising the 
potential for route of delivery to effect our findings! (Abdulla et al. 2014). Finally, we 
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acknowledge that these findings may not represent those found in an alternative cohort (e.g. 
those with co-morbidities or difference baseline characteristics). For example, it may be that 
in sarcopenic or obese individuals reduced MBF is indeed a facet of blunted responses to 
anabolic stimuli for which cocoa flavanols may be beneficial. Similarly this may also be true 
for older females who have been shown to have distinct anabolic responses to males (Smith 
et al. 2008, Smith et al. 2012) despite similarly blunted leg blood flow responses to feeding 
(Bukhari et al. 2015). 
 
To conclude, we have shown that macro- and microvascular blood flow responses to mixed 
nutrition (I.V AA (~20 g AA, 8 g EAA (equivalent to a small chicken portion or 20 g whey 
protein) and dextrose) can be improved by acute cocoa supplementation in older men, but 
that this improvement does not enhance muscle protein anabolic responses to nutrition. These 
data imply that neutraceutical strategies based on cocoa flavanol supplementation could be 
used to improve muscle microvascular recruitment in postprandial periods, which although 
may not have positive effects on muscle protein metabolism, could positively impact on other 
aspects of metabolism (i.e. insulin sensitivity, glucose clearance) in older individuals. We 
believe that this, and the potential of long-term cocoa flavanol supplementation to improve 
different elements of muscle metabolism warrant further investigation. 
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TABLES 
Table 1. Subject characteristics 
 Control Cocoa 
Body mass Index (kg·m2) 26.5±1.2 25.0±0.8 
Lean whole body mass (kg) 52.1±1.66 53.4±1.22 
Lean leg mass (kg) 8.42±0.43 8.71±0.29 
Fasting glucose (mmol·l-1) 5.1±0.1 5.3±0.2 
Systolic BP (mmHg) 132±4 134±5 
Diastolic BP (mmHg) 85±3 83±3 
Resting HR (bpm) 66±2 60±3 
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Table 2. Glamin¨ composition per 1000 mL 
Constituent Content (g) Constituent Content (g) 
Alanine 16.0 
Leucine 
7.90 
Arginine 11.30 Lysine-Acetate: 
Corresp to Lysine 
12.70 
9.0 Aspartic Acid 
3.40 
Glutamic Acid 5.60 Methionine 5.60 
Glycyl-Glutamine: 
Corresp to Glycine 
Corresp to Glutamine 
30.27 
10.27 
20.0 
Phenylalanine 5.85 
Proline 6.80 
Serine 4.50 
Glycyl-Tyrosine: 
Corresp. to Glycine 
Corresp. to Tyrosine 
3.45 
0.94 
2.28 
Threonine 5.60 
Tryptophan 1.90 
Valine 7.30 
Histidine 6.80 Citric Acid to pH 5.8 
Isoleucine 5.60 Water to 1000 mL 
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FIGURE CAPTIONS 
Figure 1. Acute study protocol 
 
Figure 2. Femoral artery blood flow in old male subjects in BASAL (post-absorptive) and 
FED conditions (102mg·kg·h-1 Glamin and 20% dextrose to maintain blood glucose between 
7-7.5 mmol·l-1) with (Cocoa) and without (Control) the addition of 350 mg cocoa flavanols. 
Values are means ± SEM for n=10 in each group. **P<0.01 vs. BASAL in the same group; ^ 
P<0.05 vs. Control in the same condition. BASAL to FED comparisons via paired studentÕs t-
test. Group comparisons via ANOVA with Bonferroni post-hoc analysis. 
 
Figure 3. Microvascular refilling curves after destruction of Definity microbubbles in old 
male subjects in BASAL (post-absorptive) and FED conditions with (Cocoa; C) and without 
(Control; A) 350 mg cocoa flavanols. Microvascular blood volume presented as the plateau 
value acoustic index (A value) in old male subjects in BASAL and FED conditions with 
(Cocoa; D) and without (Control; B) 350 mg cocoa flavanols. Values are means ± SEM for 
n=10 in each group. **P<0.001 vs. BASAL. Analysis via paired studentÕs t-test. 
 
Figure 4. Muscle protein synthesis in response to feeding with (Cocoa) and without (Control) 
350 mg cocoa flavanols in old male subjects. Values are means ± SEM for n=10 in each 
group. **P<0.01 vs. BASAL. BASAL to FED comparisons via paired studentÕs t-test. Group 
comparisons via ANOVA with Bonferroni post-hoc analysis. 
 
Figure 5. Dextrose infusion (20%) required to maintain a blood glucose value of 7-7.5 
mmol·l-1 and plasma insulin values in response to feeding with (Cocoa) and without (Control) 
	 31	
350 mg cocoa flavanols in old male subjects. Values are means ± SEM for n=10 in each 
group. 
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FIGURES 
Figure 1 
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Figure 2  
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Figure 3 
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Figure 4 
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Figure 5 
 
